These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 497668)

  • 1. Genetic association with bladder cancer.
    Br Med J; 1979 Sep; 2(6189):514. PubMed ID: 497668
    [No Abstract]   [Full Text] [Related]  

  • 2. HL-A antigens and transitional-cell carcinoma of the bladder.
    Arce S; López R; Almaguer M; Ballester JM; Filgueiras E; Ustariz C; Pérez S; Hernández E
    Mater Med Pol; 1978; 10(2):98-100. PubMed ID: 81357
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunologic indices of patients with transitional cell carcinoma of the urinary bladder].
    Bkhatta AD; Makhlin NV
    Urol Nefrol (Mosk); 1984; (2):67-70. PubMed ID: 6372193
    [No Abstract]   [Full Text] [Related]  

  • 4. Association of ABO (H) antigen negative transitional cell tumours with abnormal mucosal biopsies in superficial bladder cancer.
    Das G
    Arch Ital Urol Nefrol Androl; 1988 Sep; 60(3):295-9. PubMed ID: 2975863
    [No Abstract]   [Full Text] [Related]  

  • 5. [Determination of surface ABO(H) isoantigens in transitional cell carcinoma of the bladder. Clinicopathological study. (Part 1)].
    Gelabert Mas A; Corominas J; Arango O
    Actas Urol Esp; 1988; 12(3):248-53. PubMed ID: 3177059
    [No Abstract]   [Full Text] [Related]  

  • 6. [A B H isoantigens in bladder cancer. Preliminary study].
    Hernáez Manrique I; Rodríguez Trinidad A; Gastaminza A; Recarte Mendiluce JM
    Actas Urol Esp; 1983; 7(2):113-6. PubMed ID: 6880907
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antigens of the ABO blood group in the bladder urothelium: comparison of 3 technics for its detection].
    Cuadrado E; Rodríguez-Trinidad A; Blasco E; Torrado J
    Arch Esp Urol; 1985; 38(3):291-9. PubMed ID: 3904638
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunology of the bladder.
    Graham SD
    Urol Clin North Am; 1992 Aug; 19(3):541-8. PubMed ID: 1636238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Low-grade and low-stage transitional carcinoma of the bladder. Review].
    Escudero Barrilero A; Gutiérrez Sanz Gadea C; Hernández Fernández C; Romero Maroto J; Tallada Buñuel M; Perales Cabanas L
    Actas Urol Esp; 1985; 9(3):203-8. PubMed ID: 3898736
    [No Abstract]   [Full Text] [Related]  

  • 10. Blood group H antigen in transitional carcinoma of the urinary bladder.
    Tichý M; Tichá V; Jansa P; Student V; Vanák J
    Acta Univ Palacki Olomuc Fac Med; 1991; 130():157-62. PubMed ID: 1838863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Erythrocyte adherence test for identifying A, B and O(H) antigens in preneoplastic and neoplastic lesions of the bladder urothelium].
    Bertoni F; Mattarozzi A; Bacchini P
    Pathologica; 1982; 74(1032):449-61. PubMed ID: 7162862
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prognostic value of the detection of ABO surface antigens by indirect immunofluorescence technic in transitional tumors of the bladder].
    Borella T; Loro M; Dato I; Merlo F; Giudici M
    Minerva Med; 1986 Sep; 77(34-35):1527-32. PubMed ID: 3531921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro generation of cytotoxic lymphocytes by tumor extracts of transitional cell carcinoma.
    Morales A
    Natl Cancer Inst Monogr; 1978 Dec; (49):173-4. PubMed ID: 748769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunofluorescence study of the distribution of ABH cell surface antigens in bladder tumours (author's transl)].
    Vallancien G; Rouger P; Leclerc JP; Kuss R
    Sem Hop; 1982 May; 58(19):1161-4. PubMed ID: 6285497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of primary tumor bed lymphocytic infiltration and peripheral lymphocyte cytotoxicity in patients with transitional cell carcinoma.
    Jones LW; O'Toole C
    Natl Cancer Inst Monogr; 1978 Dec; (49):183-5. PubMed ID: 748770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunohistochemical demonstration of carcinoembryonic antigen (CEA) and ABO (H) blood group antigens on tissue sections of urinary bladder tumors].
    Fujioka T; Tanji S; Koike H; Kubo T; Ohhori T
    Hinyokika Kiyo; 1985 Oct; 31(10):1709-16. PubMed ID: 3911765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent diagnostic modalities for bladder cancer.
    Sheinfeld J; Cordon-Cardo C; Bander NH
    Immunol Ser; 1990; 53():485-97. PubMed ID: 2151621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis in carcinoma of the urinary bladder based upon tissue blood group abh and Thomsen-Friedenreich antigen status and karyotype of the initial tumor.
    Summers JL; Coon JS; Ward RM; Falor WH; Miller AW; Weinstein RS
    Cancer Res; 1983 Feb; 43(2):934-9. PubMed ID: 6848204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of blood group antigens in 30 patients with transitional-cell carcinomas of the bladder].
    Vieillefond A; Quillard J; Meatchi T; Benoit G; Jardin A; Martin E
    Ann Pathol; 1987; 7(1):9-14. PubMed ID: 3620025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte-mediated cytotoxicity in patients with renal and transitional cell carcinoma receiving BCG.
    Lange PH
    Natl Cancer Inst Monogr; 1978 Dec; (49):343-5. PubMed ID: 748791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.